Tablets exhibiting reduced drug release variability
View Patent ↗A compressible extended release tablet or tablet layer having a drug release profile that is not strongly dependent on tablet hardness may be prepared by dry blending a pharmaceutically active ingredient with hydroxypropyl methylcellulose, wherein the hydroxypropyl methylcellulose has a bimodal or multimodal number average molecular weight distribution that includes at least one mode over 20,000 Daltons and at least one mode under 10,000 Daltons. An additional advantage of the invention is that the tablet formulations may be prepared without resort to wet granulation.
1. A pharmaceutical tablet comprising:
an extended release formulation, the extended release formulation including a pharmaceutically active ingredient in an amount of at least 70% by weight, from about 4% to about 8% of a hydroxypropyl methylcellulose having a number average molecular weight of less than 10,000 Daltons, and from about 1% to about 10% of a hydroxypropyl methylcellulose having a number average molecular weight greater than 20,000 Daltons.
2. The extended release tablet of claim 1 , wherein the active ingredient is an analgesic.
3. The extended release tablet of claim 1 , wherein the active ingredient is acetaminophen.
4. The tablet of claim 1 , wherein the extended release formulation is in an extended release portion of a tablet further comprising an immediate release portion containing a pharmaceutically active ingredient, which is the same or different from the pharmaceutically active ingredient in the extended release portion, and at least one disintegrant.
5. The tablet of claim 4 , wherein the active ingredient in the extended release portion is an analgesic.
6. The tablet of claim 4 , wherein the active ingredient in the extended release portion is acetaminophen.